John B. Morris

4.7k total citations · 2 hit papers
104 papers, 3.6k citations indexed

About

John B. Morris is a scholar working on Pulmonary and Respiratory Medicine, Sensory Systems and Biomedical Engineering. According to data from OpenAlex, John B. Morris has authored 104 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 25 papers in Sensory Systems and 14 papers in Biomedical Engineering. Recurrent topics in John B. Morris's work include Olfactory and Sensory Function Studies (21 papers), Inhalation and Respiratory Drug Delivery (16 papers) and Advanced Chemical Sensor Technologies (13 papers). John B. Morris is often cited by papers focused on Olfactory and Sensory Function Studies (21 papers), Inhalation and Respiratory Drug Delivery (16 papers) and Advanced Chemical Sensor Technologies (13 papers). John B. Morris collaborates with scholars based in United States, United Kingdom and Canada. John B. Morris's co-authors include W.W. Porter, Stephen G. Spanton, Walter Dziki, Rodger F. Henry, John F. Bauer, J. Quick, Sven‐Eric Jordt, Boyi Liu, Gerald Gianutsos and Kerry T. Blanchard and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

John B. Morris

98 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ritonavir: An Extraordinary Example of Conformational Polymorphism

2001 801 citations John F. Bauer, Stephen G. Spanton et al. Pharmaceutical Research profile →
Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development

2000 506 citations John F. Bauer, John B. Morris et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John B. Morris United States	29	973	604	584	460	453	104	3.6k
Peter Kovacic United States	43	1.1k 1.1×	81 0.1×	457 0.8×	540 1.2×	437 1.0×	321	8.2k
Paola Manini Italy	39	353 0.4×	131 0.2×	90 0.2×	680 1.5×	867 1.9×	187	5.0k
Masahiro Kohno Japan	48	807 0.8×	55 0.1×	159 0.3×	474 1.0×	156 0.3×	214	6.7k
Bengt Danielsson Sweden	47	496 0.5×	41 0.1×	469 0.8×	1.8k 3.9×	568 1.3×	296	7.6k
Gordon L. Flynn United States	30	308 0.3×	28 0.0×	172 0.3×	260 0.6×	276 0.6×	85	5.2k
Yashige Kotake United States	34	496 0.5×	31 0.1×	240 0.4×	188 0.4×	89 0.2×	138	3.7k
Toshio Fujita Japan	24	565 0.6×	34 0.1×	183 0.3×	234 0.5×	196 0.4×	179	3.8k
Hiroyuki Yasui Japan	42	718 0.7×	36 0.1×	41 0.1×	300 0.7×	290 0.6×	263	6.7k
Yoshiaki Kiso Japan	58	687 0.7×	24 0.0×	235 0.4×	1.1k 2.4×	192 0.4×	402	11.7k
D. D. Perrin Australia	30	756 0.8×	23 0.0×	419 0.7×	506 1.1×	240 0.5×	93	6.2k

Countries citing papers authored by John B. Morris

Since Specialization

Citations

This map shows the geographic impact of John B. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John B. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John B. Morris more than expected).

Fields of papers citing papers by John B. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John B. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John B. Morris. The network helps show where John B. Morris may publish in the future.

Co-authorship network of co-authors of John B. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of John B. Morris. A scholar is included among the top collaborators of John B. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John B. Morris. John B. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Munasinghe, Wijith, et al.. (2021). Comparative Bioavailability of Two Formulations of Biopharmaceutical Classification System (BCS) Class IV Drugs: A Case Study of Lopinavir/Ritonavir. Journal of Pharmaceutical Sciences. 110(12). 3963–3968. 7 indexed citations

Cichocki, Joseph A. & John B. Morris. (2016). Inhalation dosimetry modeling provides insights into regional respiratory tract toxicity of inhaled diacetyl. Toxicology. 388. 30–39. 6 indexed citations

Kuempel, Eileen D., Lisa Sweeney, John B. Morris, & Annie M. Jarabek. (2015). Advances in Inhalation Dosimetry Models and Methods for Occupational Risk Assessment and Exposure Limit Derivation. Journal of Occupational and Environmental Hygiene. 12(sup1). S18–S40. 79 indexed citations

Smith, Gregory J., et al.. (2015). Effects of Acetaminophen on Oxidant and Irritant Respiratory Tract Responses to Environmental Tobacco Smoke in Female Mice. Environmental Health Perspectives. 124(5). 642–650. 9 indexed citations

Liu, Boyi, et al.. (2013). TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain. 154(10). 2169–2177. 220 indexed citations

Willis, Daniel N. & John B. Morris. (2012). Modulation of Sensory Irritation Responsiveness by Adenosine and Malodorants. Chemical Senses. 38(1). 91–100. 4 indexed citations

Garren, Kevin W., et al.. (2009). Bioavailability of generic ritonavir and lopinavir/ritonavir tablet products in a dog model. Journal of Pharmaceutical Sciences. 99(2). n/a–n/a. 14 indexed citations

Morris, John B. & Ann F. Hubbs. (2008). Inhalation Dosimetry of Diacetyl and Butyric Acid, Two Components of Butter Flavoring Vapors. Toxicological Sciences. 108(1). 173–183. 47 indexed citations

North, Dakota, Kamal M. Abdo, Janet M. Benson, et al.. (2007). A review of whole animal bioassays of the carcinogenic potential of naphthalene. Regulatory Toxicology and Pharmacology. 51(2). 6–14. 28 indexed citations

10.

Klein, Cheri E., Yi‐Lin Chiu, Walid M. Awni, et al.. (2007). The Tablet Formulation of Lopinavir/Ritonavir Provides Similar Bioavailability to the Soft-Gelatin Capsule Formulation With Less Pharmacokinetic Variability and Diminished Food Effect. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(4). 401–410. 117 indexed citations

11.

Gianutsos, Gerald, et al.. (2006). Adenosine Sensory Transduction Pathways Contribute to Activation of the Sensory Irritation Response to Inspired Irritant Vapors. Toxicological Sciences. 93(2). 411–421. 29 indexed citations

12.

Shusterman, Dennis, et al.. (2005). Seasonal Allergic Rhinitic and Normal Subjects Respond Differentially to Nasal Provocation with Acetic Acid Vapor. Inhalation Toxicology. 17(3). 147–152. 25 indexed citations

13.

Symanowicz, Peter T., Gerald Gianutsos, & John B. Morris. (2004). Lack of role for the vanilloid receptor in response to several inspired irritant air pollutants in the C57Bl/6J mouse. Neuroscience Letters. 362(2). 150–153. 36 indexed citations

14.

Frederick, Clay B., Larry G. Lomax, Kurt A. Black, et al.. (2002). Use of a Hybrid Computational Fluid Dynamics and Physiologically Based Inhalation Model for Interspecies Dosimetry Comparisons of Ester Vapors. Toxicology and Applied Pharmacology. 183(1). 23–40. 36 indexed citations

15.

Morris, John B., et al.. (2001). Closed-Loop Adaptive Education. EdMedia: World Conference on Educational Media and Technology. 2001(1). 1268–1273. 1 indexed citations

16.

Bauer, John F., Stephen G. Spanton, Rodger F. Henry, et al.. (2001). Ritonavir: An Extraordinary Example of Conformational Polymorphism. Pharmaceutical Research. 18(6). 859–866. 801 indexed citations breakdown →

17.

Blanchard, Kerry T., et al.. (1996). Pulmonary Activation and Toxicity of Cyclopentadienyl Manganese Tricarbonyl. Toxicology and Applied Pharmacology. 136(2). 280–288. 5 indexed citations

18.

Morris, John B., et al.. (1994). Bioavailability to rats of iron from fortified grain amaranth. Plant Foods for Human Nutrition. 45(3). 191–201. 9 indexed citations

19.

Michel, Robert G., et al.. (1991). Laser-excited atomic fluorescence in a flame as a high-sensitivity detector for organomanganese and organotin compounds following separation by high-performance liquid chromatography. Analytical Chemistry. 63(3). 232–240. 27 indexed citations

20.

Morris, John B., et al.. (1989). Comparative pneumotoxicity of cyclopentadienyl manganese tricarbonyl and methylcyclopentadienyl manganese tricarbonyl. Toxicology and Applied Pharmacology. 98(3). 434–443. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact